genOway Société anonyme (EPA:ALGEN)

France flag France · Delayed Price · Currency is EUR
3.040
0.00 (0.00%)
Mar 28, 2025, 12:58 PM CET
-26.75%
Market Cap 28.58M
Revenue (ttm) 28.08M
Net Income (ttm) 1.26M
Shares Out 9.22M
EPS (ttm) n/a
PE Ratio 22.76
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 28,206
Average Volume 5,346
Open 3.040
Previous Close 3.040
Day's Range 3.040 - 3.180
52-Week Range 2.840 - 4.690
Beta 0.52
RSI 33.48
Earnings Date Mar 27, 2025

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 133
Stock Exchange Euronext Paris
Ticker Symbol ALGEN
Full Company Profile

Financial Performance

In 2023, genOway Société anonyme's revenue was 26.51 million, an increase of 25.70% compared to the previous year's 21.09 million. Earnings were 1.57 million, an increase of 101.55%.

Financial Statements

News

There is no news available yet.